Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michelle Arielle Worst"'
Autor:
Sarah Elizabeth Bomba, Emily S. Mikhael, Megan Whitney, Ahmad Sarris, Michelle Arielle Worst, Joseph R Mikhael
Publikováno v:
Blood. 140:13109-13110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::327473b867e9fcdec38b2f439c8a163e
https://doi.org/10.1182/blood-2022-163599
https://doi.org/10.1182/blood-2022-163599
Publikováno v:
Journal of Clinical Oncology. 40:e23004-e23004
e23004 Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare, heterogenous neoplasms characterized by a wide spectrum of clinical manifestations. Management strategies are varied and include surgery, radiological intervention,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00caa0a1fe82d2ca26ddbaff2b216036
https://doi.org/10.1200/jco.2022.40.16_suppl.e23004
https://doi.org/10.1200/jco.2022.40.16_suppl.e23004
Publikováno v:
Neuro Oncol
BACKGROUND Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition characterized by a wide spectrum of clinical findings. Patients with NF1 develop benign and malignant tumors along the nerves of the skin, brain, and other body part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34955514c66e5756d9922ddbef3ceda1
https://europepmc.org/articles/PMC7651669/
https://europepmc.org/articles/PMC7651669/
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A664-A664
BackgroundMalignant pleural mesothelioma (MPM) is a rare and aggressive inflammatory cancer commonly associated with prior exposure to asbestos. Until recently, approved systemic treatments for MPM have been limited to chemotherapy regimens that have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f15daf73d0e7594c79cf03dea679f15d
https://doi.org/10.1136/jitc-2021-sitc2021.635
https://doi.org/10.1136/jitc-2021-sitc2021.635
Publikováno v:
Journal of Clinical Oncology. 39:e23008-e23008
e23008 Background: Although relatively rare, neurotrophic receptor tyrosine kinase (NTRK) fusions, represent a clinically relevant subgroup of NSCLC that can derive benefit from targeted therapies. Relatively quick and durable responses have been ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bff3f7c9a5047a5c254894bfe9fb331
https://doi.org/10.1200/jco.2021.39.15_suppl.e23008
https://doi.org/10.1200/jco.2021.39.15_suppl.e23008
Autor:
Michelle Arielle Worst, Ann Carothers, Timothy F. Cloughesy, Giuseppe Lombardi, Lisa Brauer, Kinjal Parikh
Publikováno v:
Journal of Clinical Oncology. 38:11026-11026
11026 Background: Glioblastoma multiforme (GBM) is a rare, malignant tumor of the central nervous system (CNS) with poor prognosis. Nearly all patients experience recurrence due to GBM’s heterogeneity and there is currently no standard approach to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d216ab1c3dc2c5903f44d59ab424f71
https://doi.org/10.1200/jco.2020.38.15_suppl.11026
https://doi.org/10.1200/jco.2020.38.15_suppl.11026
Autor:
Mindy Tanzola, Emily Sherene Van Laar, Victor M. Villalobos, Michelle Arielle Worst, Michael Heinrich
Publikováno v:
Journal of Clinical Oncology. 38:837-837
837 Background: Gastrointestinal stromal tumors (GIST) are rare soft-tissue sarcomas that harbor specific genomic alterations, making GIST an ideal model for targeted therapy. Common oncogenic drivers include mutations in the KIT and PDGFR tyrosine k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8edccb14f8f1db07f6388f7c0d629bb0
https://doi.org/10.1200/jco.2020.38.4_suppl.837
https://doi.org/10.1200/jco.2020.38.4_suppl.837